[Report on 93rd AACR].
UMR CNRS 6543, Institut Signalisation, Biologie du développement et cancer, parc Valrose, 06108 Nice Cedex 2, France.
Gilles
G
L'Allemain
D020533:Angiogenesis Inhibitors / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005419:Flavonoids / Q000627:therapeutic use; D006801:Humans; D008495:Medical Oncology; D010880:Piperidines / Q000627:therapeutic use; D012955:Societies, Medical; D014481:United States
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D005419:Flavonoids; D010880:Piperidines; C077990:alvocidib; D066246:ErbB Receptors